Search Our Research

Creating New Treatments for Metastatic Breast Cancer

Advanced estrogen receptor positive (ER+) breast cancer is responsible for over half of breast cance ...
Read more...

Using Epigenetics to Prevent Breast Cancer

Our current understanding of personal, familial and genetic risk factors for breast cancer provides ...
Read more...

Improving Treatment Options for Rare Breast Cancers

Most breast cancers are carcinomas, which are tumours that start in the surface cells that line the ...
Read more...

Repurposing an Existing Therapy for Triple-Negative Breast Cancer

Triple negative breast cancers (TNBCs) are present in up to 20% of breast cancer patients. Unfortun ...
Read more...

Fast-Tracking Pro-Survival Proteins from the Lab to the Clinic

Certain blood cancers are sustained by high levels of a ‘survival’ protein called BCL-2, which m ...
Read more...

Reducing the Burden of Cardiovascular Disease from Breast Cancer

Cardiovascular disease is a potential complication of breast cancer treatment and is the second-lead ...
Read more...

Anti-Cancer Drugs for Advanced and Resistant Breast Cancer

Breast cancer tumours can become resistant to treatment through a number of mechanisms, including ch ...
Read more...

Using a State of the Art Tumour Bank to Investigate Drug Resistant Breast Cancer

Metastasis is an incurable spread of cancer and is the main cause of cancer death. It is evident tha ...
Read more...

A New Way to Attack the Most Aggressive Breast Cancer

Despite improvements in outcomes over the past decade, women with aggressive breast cancer subtypes ...
Read more...

Pin-Pointing Cancer-Causing Mutations on a New Breast Cancer Gene

Breast cancer caused by inherited predisposition makes up about 10% of cases. It occurs at younger a ...
Read more...